HOME - The Journal of Precision Medicine

LATEST NEWS

Illumina Appoints Bob Ragusa as Chief Executive Officer (CEO) of GRAIL

adminpmls20162021-10-15T09:54:53-05:00October 15th, 2021|

PathAI Announces Strategic Partnership with Roche to Enable Development and Distribution of Digital Pathology Diagnostics

adminpmls20162021-10-15T09:25:57-05:00October 15th, 2021|

Terasaki Institute for Biomedical Innovation Signs Agreement with Qatar Foundation

adminpmls20162021-10-14T15:38:37-05:00October 14th, 2021|

Pillar Biosciences to Collaborate with Labcorp on Precision Genomic Cancer Testing Using Next-Generation Sequencing

adminpmls20162021-10-14T10:20:57-05:00October 14th, 2021|

Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast Cancer

adminpmls20162021-10-14T10:04:13-05:00October 14th, 2021|

Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel Precision Therapies for Brain Diseases

adminpmls20162021-10-14T09:59:24-05:00October 14th, 2021|

Caris Life Sciences and Ono Pharmaceutical Announce Strategic Collaboration

adminpmls20162021-10-14T09:57:05-05:00October 14th, 2021|

Bionano Genomics to Acquire BioDiscovery

adminpmls20162021-10-14T09:52:48-05:00October 14th, 2021|

Lilly and Susan G. Komen® Partner to Address Disparities in Breast Cancer Outcomes Experienced By Black Women

adminpmls20162021-09-30T11:52:55-05:00September 30th, 2021|

Great discussion taking place now at PMLS PGx event OneOme, Mayo Clinic, Weill Cornell and Univ of Minnesota "The I… twitter.com/i/web/status/1…
3 days ago
Illumina Appoints Bob Ragusa as Chief Executive Officer (CEO) of GRAIL - thejournalofprecisionmedicine.com/illumina-appoi…
7 days ago
PathAI Announces Strategic Partnership with Roche to Enable Development and Distribution of Digital Pathology Diagn… twitter.com/i/web/status/1…
7 days ago

LATEST ISSUE

The Journal of Precision Medicine - September 2021

The Integration of Personalized Medicine into Healthcare: Advancing the Promise to More Patients

The value of adding RNA sequencing to precision biomarker strategy

As Targeted Therapies Expand Beyond Cancer, Companion Diagnostics Must Improve

Tissue-Based Multiplex Biomarker Assays and Companion Diagnostics

Improving Patient Outcomes Through the Integration of Pharmacogenomic Testing into Comprehensive Medication Management Care Models

Part 2: Industry challenges and opportunities for the integration of precision medicine tools at the point of care

The Power and the Promise: Integrating Pharmacogenomics into Clinical Practice – Designing a PGx Program That Works

The In Vitro Diagnostic Regulation in Europe: Implications for Precision Medicine and Pharmaceutical Development

A Comprehensive Genomic Landscape for Amyotrophic Lateral Sclerosis (ALS) to Support Precision Medicine Initiatives

Part 1: Surveillance of Wastewater and Prevention Platform (SWAPP): A Case Study of Digital Public Health and SARS-CoV-2

NGS and circulating markers in the clinic at UPMC

The role of UK Biobank

To what extent does Precision Medicine play a role in shaping the future diagnostics and treatment of Cystic Fibrosis?

ARCHIVE ISSUES

September 2021

Articles include:
The Integration of Personalized Medicine into Healthcare: Advancing the Promise to More Patients, The value of adding RNA sequencing to precision biomarker strategy, As Targeted Therapies Expand Beyond Cancer, Companion Diagnostics Must Improve.

Read More

June 2021

Articles include:
myRabble: A novel patient platform to improve access to personalized medicine, Clinical data and precision medicine: The urgent need for in‑house NGS capabilities at community hospitals.

Read More

March 2021

Articles include:
Integrating biomarker and translational research in a drug development pipeline, Early Detection of Cancer: Transitioning from Emerging to Established Companies and Technologies.

Read More

The Journal of Precision Medicine - December

December 2020

Articles include:
Letter to the Journal: The COVID-19 innovation race, a case study
Personalised Medicine and Disease Modification in Osteoarthritis: On our journey but still a way to go!

Read More

LATEST NEWS

Illumina Appoints Bob Ragusa as Chief Executive Officer (CEO) of GRAIL

PathAI Announces Strategic Partnership with Roche to Enable Development and Distribution of Digital Pathology Diagnostics

Terasaki Institute for Biomedical Innovation Signs Agreement with Qatar Foundation

Pillar Biosciences to Collaborate with Labcorp on Precision Genomic Cancer Testing Using Next-Generation Sequencing

Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast Cancer

Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel Precision Therapies for Brain Diseases

Caris Life Sciences and Ono Pharmaceutical Announce Strategic Collaboration

Bionano Genomics to Acquire BioDiscovery

Lilly and Susan G. Komen® Partner to Address Disparities in Breast Cancer Outcomes Experienced By Black Women

Recent Tweets

LATEST ISSUE

ARCHIVE ISSUES

September 2021

June 2021

March 2021

December 2020

SUBSCRIBE